pubmed-article:10932458 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C1948070 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C0042462 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C0025071 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C0020592 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C0020591 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C0206176 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C0039711 | lld:lifeskim |
pubmed-article:10932458 | lifeskim:mentions | umls-concept:C2728259 | lld:lifeskim |
pubmed-article:10932458 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:10932458 | pubmed:dateCreated | 2000-9-8 | lld:pubmed |
pubmed-article:10932458 | pubmed:abstractText | To assess use of sedative/hypnotic agents in Texas Medicaid patients and evaluate practitioner receptiveness to intervention letters concerning sedative/hypnotic prescribing generated by the Texas Medicaid Drug Utilization Review (DUR) Board. | lld:pubmed |
pubmed-article:10932458 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10932458 | pubmed:language | eng | lld:pubmed |
pubmed-article:10932458 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10932458 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10932458 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10932458 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10932458 | pubmed:issn | 1086-5802 | lld:pubmed |
pubmed-article:10932458 | pubmed:author | pubmed-author:KurtT LTL | lld:pubmed |
pubmed-article:10932458 | pubmed:author | pubmed-author:DeanBB | lld:pubmed |
pubmed-article:10932458 | pubmed:author | pubmed-author:KnodelL CLC | lld:pubmed |
pubmed-article:10932458 | pubmed:author | pubmed-author:BurchCC | lld:pubmed |
pubmed-article:10932458 | pubmed:author | pubmed-author:SeltzerJ KJK | lld:pubmed |
pubmed-article:10932458 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10932458 | pubmed:volume | 40 | lld:pubmed |
pubmed-article:10932458 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10932458 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10932458 | pubmed:pagination | 495-9 | lld:pubmed |
pubmed-article:10932458 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:meshHeading | pubmed-meshheading:10932458... | lld:pubmed |
pubmed-article:10932458 | pubmed:articleTitle | Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board. | lld:pubmed |
pubmed-article:10932458 | pubmed:affiliation | Department of Pharmacology, UTHSCSA 78229-3900, USA. seltzer@uthscsa.edu | lld:pubmed |
pubmed-article:10932458 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10932458 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10932458 | lld:pubmed |